![GeneVentiv to Attend BIO CEO & Investor Conference](https://www.geneventiv.com/wp-content/uploads/2024/02/BIO-CEO-Investor-Conference-2024.jpg)
![GeneVentiv to Attend BIO CEO & Investor Conference](https://www.geneventiv.com/wp-content/uploads/2024/02/BIO-CEO-Investor-Conference-2024.jpg)
Recent Posts
- GeneVentiv Welcomes New Scientific Advisory Board Member, Sylvia Fong
- GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors
- New partners to develop universal gene therapy for hemophilia
- ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
- GeneVentiv to Attend BIO CEO & Investor Conference
Recent Comments